MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.pharmthera.2013.11.009

Медицинская библиотека · Pharmacology & therapeutics · 2013

p53 in neurodegenerative diseases and brain cancers.

Checler Frédéric, Alves da Costa Cristine

СтатьяПоддержка исследования: вне правительства СШАОбзорПеревод в очереди

Аннотация

More than thirty years elapsed since a protein, not yet called p53 at the time, was detected to bind SV40 during viral infection. Thousands of papers later, p53 evolved as the main tumor suppressor involved in growth arrest and apoptosis. A lot has been done but the protein has not yet revealed all its secrets. Particularly important is the observation that in totally distinct pathologies where apoptosis is either exacerbated or impaired, p53 appears to play a central role. This is exemplified for Alzheimer's and Parkinson's diseases that represent the two main causes of age-related neurodegenerative affections, where cell death enhancement appears as one of the main etiological paradigms. Conversely, in cancers, about half of the cases are linked to mutations in p53 leading to the impairment of p53-dependent apoptosis. The involvement of p53 in these pathologies has driven a huge amount of studies aimed at designing chemical tools or biological approaches to rescue p53 defects or over-activity. Here, we describe the data linking p53 to neurodegenerative diseases and brain cancers, and we document the various strategies to interfere with p53 dysfunctions in these disorders.

Для цитирования: Checler Frédéric, Alves da Costa Cristine. p53 in neurodegenerative diseases and brain cancers.. Pharmacology & therapeutics. 2013. DOI: 10.1016/j.pharmthera.2013.11.009.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.